Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 23, 2024 07:00 ET | Source: Biogen Inc.

Biogen’s QALSODY® (tofersen), the First Therapy to Treat Rare, Genetic Form of ALS, Received Positive Opinion from CHMP

SOD1-ALS is a devastating, uniformly fatal, and ultra-rare genetic form of ALS affecting less than 1,000 people in Europe1With QALSODY, Biogen has advanced the role of neurofilament in the development...
December 06, 2023 02:00 ET | Source: LifeArc

LifeArc announces £5 million drug repurposing programme for motor neuron disease

MEDIA RELEASE LifeArc announces £5 million drug repurposing programme for motor neuron disease LifeArc is launching new £5m programme to help find new treatments for motor neuron disease (MND).The...